APO-CAPECITABINE capecitabine 500 mg tablet blister pack

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

capecitabine, Quantity: 500 mg

可用日期:

Arrotex Pharmaceuticals Pty Ltd

INN（国际名称）:

Capecitabine

药物剂型:

Tablet, film coated

组成:

Excipient Ingredients: magnesium stearate; iron oxide yellow; titanium dioxide; lactose; colloidal anhydrous silica; methylcellulose; iron oxide red; hyprolose; croscarmellose sodium; hypromellose; macrogol 8000

给药途径:

Oral

每包单位数:

120

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

Colon Cancer,Capecitabine is indicated for the adjuvant treatment of patients with Dukes' stage C and high-risk stage B, colon cancer, either as monotherapy or in combination with oxaliplatin.,Colorectal Cancer,Capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,Oesophagogastric Cancer,Capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,Breast Cancer,Capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated.,Capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

產品總結:

Visual Identification: Peach, oval, biconvex, film-coated tablet. Engraved APO on one side, C500 on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

授权状态:

Licence status A

授权日期:

2014-01-16